These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Prevalence of HLA-B27 antigens in patients with dialysis-related beta 2-M amyloidosis. Charmes JP; Drouet M; Leroux-Robert C; Ton That H; Bouteiller G Clin Nephrol; 1991 Oct; 36(4):214. PubMed ID: 1959251 [No Abstract] [Full Text] [Related]
11. New aspects in the pathogenesis of dialysis-related amyloidosis: role of beta 2-microglobulin modified with advanced glycation end products in bone and joint destruction. Miyata T; Maeda K Nephrol Dial Transplant; 1996; 11 Suppl 2():140-3. PubMed ID: 8804015 [No Abstract] [Full Text] [Related]
12. Dialysis-related amyloidosis: history and clinical manifestations. Danesh F; Ho LT Semin Dial; 2001; 14(2):80-5. PubMed ID: 11264771 [TBL] [Abstract][Full Text] [Related]
16. Amyloid, advanced glycation end products, and dialysis related arthropathy. McDonald SP; Coates PT; Disney AP Ann Rheum Dis; 1998 Apr; 57(4):193-5. PubMed ID: 9709172 [No Abstract] [Full Text] [Related]